DUBLIN, Feb. 4, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/2ssngw/global) has announced the addition of the "Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials" company profile to their offering.
Global Cardiovascular Partnering 2010 to 2016 provides the full collection of Cardiovascular disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Cardiovascular disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Cardiovascular deals.
The report presents financial deal terms values for Cardiovascular deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
Report scope
In Global Cardiovascular Partnering 2010-2016: Deal trends, players and financials, the available deals are listed by:
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Cardiovascular dealmaking
Chapter 3 - Financial deal terms for Cardiovascular partnering
Chapter 4 - Leading Cardiovascular deals and dealmakers
Chapter 5 - Cardiovascular contract document directory
Chapter 6 - Cardiovascular dealmaking by therapeutic target
For more information visit
http://www.researchandmarkets.com/research/2ssngw/global
Media Contact:
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article